Market Research Report
Global Rat Model Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||513980|
|Published||Content info||130 Pages
Delivery time: 2-3 business days
|Global Rat Model Market Forecast 2019-2027|
|Published: January 20, 2019||Content info: 130 Pages||
The global rat model market was worth $XX thousand in the year 2018 and is expected to grow at a CAGR of 8.08% for the forecast period of 2019-2027. It is anticipated that the market worth would be around $XX thousand by the year 2027. The main reason for the potential growth of the market is the fact that the rat models are more suitable for medical as well as pharmaceutical research as compared to other animal models used.
The global rat model market can be segmented on the basis of various categories like application, rat model types, components and rat care products. Rapid and increasing availability in transgenic rat methodologies, improving genome-editing techniques and the growing research and developments in pharmaceutical and biotechnological companies are the major drivers for the growth of the rat model market. The oncology application market is fast growing at a CAGR of xx%. However, the toxicology market is currently dominating the application segment of the market. The immunology & inflammation markets are expected to grow at a CAGR of xx% during the forecast period. With respect to the types of rat models, the current market scenario shows an anticipated CAGR of xx%, xx%, xx% and xx% respectively for the inbred rats, immune-deficient rat, surgically modified rats and hybrid type rat model. The rat care product had contributed to xx% of the market share in the year 2018 and is expected to grow at a CAGR of xx% by the year 2027.
The North-American rat model market is expected to hold the highest share by the year 2027 with the US market contributing to the majority of the share owing to the increased demand for rat models in the pre-clinical animal trials by companies such as Novartis, Merck & Co, Roche, etc. in this region. The Asia-Pacific market is fast flourishing, especially in regions like India, China and Australia because of the novel R&D incentive schemes for the pharmaceutical companies and the contract research organizations (CROs). The market is predicted to grow at a CAGR of xx% during the forecast period in the APAC region. The United Kingdom is currently the leader in the European rat model market mainly because of the lucrative R&D revenue schemes and the growing interest of the commercial investors in the region.
The major players in the global rat model market are Taconic Biosciences, Envigo, Laboratory Corporation of America Holdings, Transviragen Inc., Charles River Laboratories Inc., Transposagen Biopharmaceuticals Inc., Janvier Labs, Vivo Biotech Ltd., Biomere, Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Oncodesign S.A., Cyagen Biosciences Inc., Genoway S.A., Clea Japan and Hera Biolabs Inc. have the largest laboratory network around the world with most of its research focusing on genomics.